Pharmabiz1d
Santhera announces agreement with German GKV-SV on reimbursement for Agamree to treat Duchenne muscular dystrophy
Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...
Genetic mechanisms underlying Duchenne muscular dystrophy point to potential treatments
Duchenne muscular dystrophy (DMD) is a rare hereditary disease that is associated with progressive muscle wasting. The ...
Managed Healthcare Executive2d
Entrada Therapeutics On Track For New DMD Study in the U.K.
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Max Planck Society2d
Mechanism for treating muscle wasting discovered
Utrophin increase in muscle cells after transcriptional adaptation normalises cell function in Duchenne muscular dystrophy ...
Expert explains how to improve heart health, even if your family has history of heart conditions
It's not unusual to have one or more family members with some form of heart disease. Nonetheless, some people may not even ...
The American Journal of Managed Care7d
Ifetroban Improves Heart Function in DMD
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
Armagh I8d
‘Time is muscle’: Parents of Newry boy with DMD call for immediate response to ‘life-changing’ drug approval
The parents of a young Newry boy living with Duchenne Muscular Dystrophy (DMD) are calling for immediate action from ...
Wave Life Sciences begins Phase 1 obesity trial
CAMBRIDGE, Mass. - Wave Life Sciences Ltd . (NASDAQ:WVE), a clinical-stage biotechnology company with a market capitalization of $1.87 billion, has announced the commencement of its Phase 1 INLIGHT ...
Cyprus Mail10d
TELETHON’s charity gala dinner in Paphos a radiant night of giving
In an evening of generosity and solidarity, the TELETHON charity gala dinner was held successfully on February 1, 2025.